CELLNOVO
They believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition. The experience of managing diabetes should be as positive as possible. Thoughtful and innovative design should make things easier to understand and simpler to use. With belief in these ideals, they tore up convention. When they started, they did so with a focus only on how modern technology and beautiful design would make life easier for someone managing diabetes.
CELLNOVO
Industry:
Biotechnology Diabetes Health Care Medical Device
Founded:
2002-01-01
Address:
Wales, Cumbria, United Kingdom
Country:
United Kingdom
Total Employee:
51+
Status:
Closed
Contact:
44 20 3058 1250
Email Addresses:
[email protected]
Total Funding:
102.54 M USD
Technology used in webpage:
Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - CellNovo
Kreos Capital
Kreos Capital investment in Post-IPO Debt - CellNovo
Nesta Ventures
Nesta Ventures investment in Series B - CellNovo
Andera Partners
Andera Partners investment in Series B - CellNovo
HealthCare Ventures
HealthCare Ventures investment in Series B - CellNovo
Omnes Capital
Omnes Capital investment in Series B - CellNovo
Advent Venture Partners
Advent Venture Partners investment in Series B - CellNovo
Auriga Partners
Auriga Partners investment in Series B - CellNovo
Forbion Capital Partners
Forbion Capital Partners investment in Series B - CellNovo
NBGI Ventures
NBGI Ventures investment in Series B - CellNovo